CY2167B1 - Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders - Google Patents

Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders

Info

Publication number
CY2167B1
CY2167B1 CY0000012A CY0000012A CY2167B1 CY 2167 B1 CY2167 B1 CY 2167B1 CY 0000012 A CY0000012 A CY 0000012A CY 0000012 A CY0000012 A CY 0000012A CY 2167 B1 CY2167 B1 CY 2167B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
benzimidazole
methylsulfinylue
difluoromethoxy
dimethoxy
Prior art date
Application number
CY0000012A
Other languages
English (en)
Inventor
Michael E Parsons
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10681166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2167(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2167B1 publication Critical patent/CY2167B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CY0000012A 1990-08-24 2000-05-02 Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders CY2167B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909018603A GB9018603D0 (en) 1990-08-24 1990-08-24 Compositions

Publications (1)

Publication Number Publication Date
CY2167B1 true CY2167B1 (en) 2002-08-23

Family

ID=10681166

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000012A CY2167B1 (en) 1990-08-24 2000-05-02 Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders

Country Status (13)

Country Link
EP (1) EP0544760B1 (xx)
JP (1) JPH06503806A (xx)
KR (1) KR930701166A (xx)
AT (1) ATE152350T1 (xx)
AU (1) AU658831B2 (xx)
CA (1) CA2089748C (xx)
CY (1) CY2167B1 (xx)
DE (1) DE69125940T2 (xx)
DK (1) DK0544760T3 (xx)
ES (1) ES2103825T3 (xx)
GB (1) GB9018603D0 (xx)
GR (1) GR3024058T3 (xx)
WO (1) WO1992003135A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW276996B (xx) * 1992-04-24 1996-06-01 Astra Ab
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
WO1994027606A1 (en) * 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
TW420610B (en) * 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
WO1996016053A1 (en) * 1994-11-21 1996-05-30 Pfizer Pharmaceuticals Inc. Phthalide compounds and their production process
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
PT1003554E (pt) 1997-07-25 2005-03-31 Altana Pharma Ag Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
WO1992003135A1 (en) 1992-03-05
AU8424091A (en) 1992-03-17
JPH06503806A (ja) 1994-04-28
DK0544760T3 (da) 1997-09-22
DE69125940T2 (de) 1997-12-18
DE69125940D1 (de) 1997-06-05
CA2089748C (en) 2005-07-05
AU658831B2 (en) 1995-05-04
EP0544760B1 (en) 1997-05-02
ES2103825T3 (es) 1997-10-01
ATE152350T1 (de) 1997-05-15
KR930701166A (ko) 1993-06-11
GB9018603D0 (en) 1990-10-10
EP0544760A1 (en) 1993-06-09
CA2089748A1 (en) 1992-02-25
GR3024058T3 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
CS553490A3 (en) Transdermal therapeutic system
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
CY2167B1 (en) Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinylue benzimidazole and an anti-helicobacter agent f or the treatment of gastrointestinal disorders
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
GB9103764D0 (en) Compositions
BG102667A (en) Diosgenine-containing composition
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
GR3007995T3 (xx)
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
MY127662A (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ZA925765B (en) Use of di-tert.Butylhydroxyphenyl derivatives for the treatment of the gastrointestinal tract
CA2239422A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders